Back to STATE STREET CORP STATE STREET CORP

ESPRESPR
28 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ESPERION THERAPEUTICS INC NE

STATE STREET CORP holds 7.3M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $23M as of 2026-Q2. The position was increased (+3.1% shares). ESPR represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$23M

Current Shares

7.3M

Total Value Change

-$29.9M

Total Shares Change

+5.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.3M
+3.1%
$23M0.0%$3.16
29
2026-Q1
Increased
7.1M
+19.0%
$19.3M0.0%$2.91
33
2025-Q4
Increased
5.9M
+32.4%
$21.9M0.0%$3.69
36
2025-Q3
Increased
4.5M
+19.2%
$11.9M0.0%$2.64
33
2025-Q2
Decreased
3.8M
-17.4%
$3.7M0.0%$0.99
0
2025-Q1
Increased
4.5M
+1.0%
$6.5M0.0%$1.50
27
2024-Q4
Increased
4.5M
+16.9%
$9.9M0.0%$2.15
32
2024-Q3
Increased
3.9M
+2.7%
$6.4M0.0%$1.68
28
2024-Q2
Increased
3.8M
+581.1%
$8.3M0.0%$2.22
44
2024-Q1
Increased
551,249
+43.6%
$1.5M0.0%$2.68
34
2023-Q4
Increased
383,749
+26.9%
$1.1M0.0%$2.99
31
2023-Q3
Unchanged
302,449
0.0%
$296,4000.0%$0.98
0
2023-Q2
Decreased
302,449
-84.1%
$420,4040.0%$1.34
0
2023-Q1
Increased
1.9M
+8.5%
$3M0.0%$1.67
29
2022-Q4
Increased
1.8M
+14.4%
$10.9M0.0%$6.23
32
2022-Q3
Increased
1.5M
+23.2%
$10.3M0.0%$6.84
34
2022-Q2
Increased
1.2M
+35.8%
$7.9M0.0%$6.67
36
2022-Q1
Decreased
916,438
-12.4%
$4.3M0.0%$4.89
0
2021-Q4
Increased
1M
+81.3%
$5.2M0.0%$4.96
41
2021-Q3
Decreased
577,281
-74.4%
$7M0.0%$12.44
0
2021-Q2
Increased
2.3M
+6.3%
$47.6M0.0%$21.13
31
2021-Q1
Decreased
2.1M
-16.0%
$59.4M0.0%$27.44
0
2020-Q4
Increased
2.5M
+39.9%
$65.6M0.0%$28.15
39
2020-Q3
Increased
1.8M
+3.1%
$67M0.0%$37.46
31
2020-Q2
Increased
1.7M
+57.9%
$89.7M0.0%$47.64
43
2020-Q1
Increased
1.1M
+0.5%
$34.9M0.0%$33.98
29
2019-Q4
Decreased
1.1M
-23.6%
$65.7M0.0%$59.82
0
2019-Q3
First report
1.4M
-
$52.9M0.0%$37.78
0

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used